Evidence map›Paper›PMID 27140063›Full record

ArticleScientific reports2016

The arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn's disease.

Sabrina Coquenlorge, Laurianne Van Landeghem, Julie Jaulin, Nicolas Cenac, Nathalie Vergnolle, Emilie Duchalais, Michel Neunlist, Malvyne Rolli-Derkinderen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Metabolites · 2025
    Article
  6. The Physiology of Enteric Glia.Annual review of physiology · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2022
    Review
  13. Synbiotic Compositions ofNutrients · 2022
    Article
  14. Review
  15. Article
  16. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Nutraceuticals and Enteric Glial Cells.Molecules (Basel, Switzerland) · 2021
    Review
  19. Maternal dietary omega-3 deficiency worsens the deleterious effects of prenatal inflammation on the gut-brain axis in the offspring across lifetime.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Sabrina CoquenlorgeINSERM, UMR913, Nantes, F-44093, France.
Laurianne Van LandeghemINSERM, UMR913, Nantes, F-44093, France.
Julie JaulinINSERM, UMR913, Nantes, F-44093, France.
Nicolas CenacCentre de Pathophysiologie, CHU Purpan, Toulouse, France.
Nathalie VergnolleCentre de Pathophysiologie, CHU Purpan, Toulouse, France.
Emilie DuchalaisINSERM, UMR913, Nantes, F-44093, France.
Michel NeunlistINSERM, UMR913, Nantes, F-44093, France.
Malvyne Rolli-DerkinderenINSERM, UMR913, Nantes, F-44093, France.
Nantes Université · FRCentre de Recherche en Nutrition Humaine Rhône-Alpes · FRCentre de Recherche en Cancérologie de Toulouse · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In healthy gut enteric glial cells (EGC) are essential to intestinal epithelial barrier (IEB) functions. In Crohn's Disease (CD), both EGC phenotype and IEB functions are altered, but putative involvement of EGC in CD pathogenesis remains unknown and study of human EGC are lacking. EGC isolated from CD and control patients showed similar expression of glial markers and EGC-derived soluble factors (IL6, TGF-β, proEGF, GSH) but CD EGC failed to increase IEB resistance and healing. Lipid profiling showed that CD EGC produced decreased amounts of 15-HETE, 18-HEPE, 15dPGJ2 and 11βPGF2α as compared to healthy EGC. They also had reduced expression of the L-PGDS and AKR1C3 enzymes. Produced by healthy EGC, the 11βPGF2 activated PPARγ receptor of intestinal epithelial cells to induce cell spreading and IEB wound repair. In addition to this novel healing mechanism our data show that CD EGC presented impaired ability to promote IEB functions through defect in L-PGDS-AKR1C3-11βPGF2α dependent pathway.

Indexed as

AdolescentAdultAgedAged, 80 and overAldo-Keto Reductase Family 1 Member C3Caco-2 CellsCells, CulturedCoculture TechniquesCrohn DiseaseDinoprostEicosapentaenoic AcidEpithelial CellsFemaleHumansHydroxyeicosatetraenoic AcidsIntestinal Mucosa15-deoxyprostaglandin J215-hydroxy-5,8,11,13-eicosatetraenoic acid18(R)-hydroxyeicosapentaenoic acidAKR1C3 protein, humanAldo-Keto Reductase Family 1 Member C3DinoprostEicosapentaenoic AcidHydroxyeicosatetraenoic AcidsProstaglandin D2

Identifiers

PMID27140063
PMCPMC4853710
OpenAlexW2345694465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.